Vasculitis & polymyalgia rheumatica

Limb arteries involvement assessed by FDG/PET CT at diagnosis of giant cell arteritis and risk of relapse: An observational study

Joint Bone SpinePublished Observational cohort study

Authors' conclusion

FDG uptake in limb arteries at diagnosis is a predictor of relapse in newly diagnosed GCA.

Study context

Population
Consecutive patients admitted with a new diagnosis of giant cell arteritis (GCA) (2022 ACR/EULAR classification criteria), May 2011–May 202298 FDG/PET CT scans reviewed
Participants
108 patients
Exposure
FDG uptake in limb arteries at diagnosis as predictors of relapse
Outcome
GCA relapse rate
Follow-up
36 months
Methodological detailsconsecutive patients, multivariable Cox regression, All patients received steroids for 21.0 [18.0-28.5] months, with MTX (n=1) or tocilizumab (n=2)
  • Consecutive patients
  • Multivariable Cox regression
  • All patients received steroids for 21.0 [18.0-28.5] months, with MTX (n=1) or tocilizumab (n=2)

Main finding

As reported in the abstract

GCA relapse · median follow-up 27.5 [11.4-35.0] months

Relapse occurred

40

37%

FDG uptake in limb arteries at diagnosis, HR [CI] for relapse (multivariable Cox)

HR 2.7

1.3–5.5P<0.01

General signs at diagnosis, HR [CI] for relapse (multivariable Cox)

HR 2.0 [1.0-4.0, P<0.05

Observational data: associations, not effects.

Original publication

Limb arteries involvement assessed by FDG/PET CT at diagnosis of giant cell arteritis and risk of relapse: An observational study. Joint Bone Spine. Published 15 April 2024. doi:10.1016/j.jbspin.2024.105734

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.